01490nas a2200205   4500000000100000008004100001260003800042653003900080653001300119653003000132653001900162653002000181653004100201653003500242100001100277245006900288300001200357520089700369020001801266       2020                            d  bSpringer International Publishing10aNeglected tropical diseases (NTDs)10aTrachoma10aLymphatic filariasis (LF)10aonchocerciasis10aschistosomiasis10aSoil-transmitted helminthiasis (STH)10amass drug administration (MDA)1 aFong I00aMass Drug Treatment of Tropical Diseases: Is It Really Progress?  a217-2393 aThere are 13 major chronic disabling diseases that are most common among the world’s poorest people, considered neglected tropical diseases that have been targeted by the World Health Organization for elimination or control. Five of the most prevalent of these (lymphatic filariasis, helminthiasis, onchocerciasis, schistosomiasis, and trachoma) have been treated by preventive chemotherapy given as mass drug treatment once or twice a year to endemic communities in tropical countries (mainly Africa and Asia) with some evidence of benefit. However, in the present era of widespread increasing global antimicrobial resistance directly related to their overuse, this policy may result in short-term gains but long-term pain from fuelling further drug resistance. This chapter reviews the current evidence of mass drug treatment of tropical diseases and potential disadvantages and concerns.  a9783030369651